Are we in an AI bubble? That's the $35 trillion dollar question right now as the stock market soars higher and higher. The problem is that bubbles are famously hard to spot. But some economists say ...

Massive AI spending by tech giants raises questions about overinvestment, but history suggests infrastructure booms don’t necessarily end in disaster. Unlike dot-com era companies, today’s AI leaders ...

This year, the development and spending around artificial intelligence has been perhaps the most significant business and economic story. AI spending is driving one of the most explosive periods for ...

Three Harvard faculty said they think fears that an artificial intelligence bubble will burst — leading stock prices to collapse in the wake of soaring investments into AI companies — are overblown ...

As Sir Isaac Newton discovered, the core scientific law of gravity is that what goes up must come down. The principle applies in many areas, which is why markets are jittery about the near-unchecked, ...

Dr. Frey is an economist at the University of Oxford and the author of the book “How Progress Ends: Technology, Innovation and the Fate of Nations.” “Bubbles are great. May the bubbles continue,” Eric ...

For almost as long as the artificial intelligence boom has been in full swing, there have been warnings of a speculative bubble that could rival the dot-com craze of the late 1990s that ended in a ...

The stock market has been running high. Too high, some analysts say. A number of Wall Street observers warn the stock market may have entered “bubble” territory. It’s an analogy to the overhyped ...

This is read by an automated voice. Please report any issues or inconsistencies here. Some tech stock declines this month have investors fearing the AI boom could burst like the dot-com bubble two ...

Forbes contributors publish independent expert analyses and insights. Jason Alan Snyder is a technologist covering AI and innovation. The AI “bubble” narrative persists because people are diagnosing ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...